跳至主要内容
临床试验/NCT05211271
NCT05211271已完成不适用

Evaluating Thermal Ablation in the Treatment of Cervical Neoplasia

International Agency for Research on Cancer2 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2018年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
86
试验地点
2
主要终点
Cure rate based on VIA and colposcopy assessment

研究概览

简要总结

Longitudinal study in Burundi to evaluate the effectiveness, the acceptability and safety of thermal ablation in the treatment of cervical neoplasia.

详细描述

The study population consisted of women with an abnormal VIA test or an abnormal colposcopy examination. A total of 86 women with lesions eligible to ablative treatment were counselled and treated by thermal ablation. Informed consent was signed by each participant. Just after treatment, they were inquired about the level of pain during the procedure, and their level of satisfaction with the treatment. They were followed-up at 6 weeks for any complication and re-assessed by VIA and colposcopy at 12 months for any persistent or recurrent lesion and for any adverse event.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • Women residing in Burundi and referred to the tertiary hospital after a positive VIA test

排除标准

  • Lesion occupying the 4 quadrants of the cervix
  • Not visible squamous columnar junction (not Type 1 TZ)
  • Vaginal or endocervical lesion
  • Lesion subjective of cervical cancer

结局指标

主要结局

Cure rate based on VIA and colposcopy assessment

时间窗: 1 year

Effectiveness is measured by the cure rate after 1 year based on VIA and colposcopy assessment.

Acceptability of thermal ablation

时间窗: At day 1

Measured by the satisfaction level using a nine-level Likert scale (from 1. Very unsatisfied to 9. very satisfied).

Safety of thermal ablation

时间窗: 1 year

Measured by existence of severe adverse events during the follow-up period.

次要结局

未报告次要终点

研究者

发起方
International Agency for Research on Cancer
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验